- €1.28bn
- €1.19bn
- €174.86m
Annual balance sheet for Pharma Mar SA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 196 | 202 | 182 | 163 | 155 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 37.2 | 78.9 | 59 | 47.8 | 42 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Current Assets | 246 | 295 | 275 | 253 | 250 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 25.5 | 30.6 | 34.7 | 47.6 | 59.1 |
Net Intangible Assets | |||||
Long Term Investments | |||||
Other Long Term Assets | |||||
Total Assets | 330 | 368 | 393 | 341 | 350 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 94.9 | 86.3 | 97.3 | 95.9 | 82.7 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Liabilities | 228 | 190 | 170 | 147 | 141 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Unrealized Gain / Loss | |||||
Total Equity | 103 | 178 | 223 | 193 | 208 |
Total Liabilities & Shareholders' Equity | 330 | 368 | 393 | 341 | 350 |
Total Common Shares Outstanding |